Sky Medex

MABTAS 100 mg Injection contains Rituximab, a chimeric monoclonal antibody that targets the CD20 antigen present on B-lymphocytes. It is commonly used in the treatment of certain blood cancers and autoimmune disorders.

Rituximab works by binding to CD20-positive B-cells and inducing their destruction through immune-mediated mechanisms such as complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and apoptosis.

Rituximab is internationally marketed under the reference brand Rituxan (also known as MabThera in various regions).

Sky High Medex supplies genuine MABTAS 100 mg Injection with reliable worldwide delivery.

VIVITRA 440 mg Injection contains Trastuzumab, a monoclonal antibody used in targeted cancer therapy for patients with HER2-positive cancers. Trastuzumab specifically targets the human epidermal growth factor receptor-2 (HER2) protein, which promotes the growth of certain cancer cells.

By binding to HER2 receptors on cancer cells, Trastuzumab blocks signals responsible for tumor growth and helps the immune system identify and destroy cancer cells. It is widely used in the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric (stomach) cancer, either alone or in combination with other chemotherapy medicines.

The reference brand of Trastuzumab is Herceptin.

Sky High Medex supplies genuine VIVITRA 440 mg Injection with reliable worldwide delivery to the USA, UK, Australia, South Korea, Japan, China, Hong Kong, Taiwan, France, Greece, Mexico, and many other international destinations.

CANMAB 440 mg Injection contains Trastuzumab, a monoclonal antibody used in targeted therapy for patients with HER2-positive cancers. Trastuzumab specifically binds to the human epidermal growth factor receptor 2 (HER2) protein, which promotes the growth and proliferation of certain cancer cells.

By targeting HER2 receptors on tumor cells, Trastuzumab blocks signals that drive cancer growth and helps the immune system identify and destroy cancer cells. It is commonly used for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric (stomach) cancer, either alone or in combination with chemotherapy.

The reference brand of Trastuzumab is Herceptin.

Sky High Medex supplies genuine CANMAB 440 mg Injection with reliable worldwide delivery to the USA, UK, Australia, South Korea, Japan, China, Hong Kong, Taiwan, France, Greece, Mexico, and many other international markets.

EMZUMAB 150 mg Injection contains Omalizumab, a monoclonal antibody used to treat moderate to severe allergic asthma and chronic spontaneous urticaria (chronic hives). It works by binding to Immunoglobulin E (IgE), reducing allergic inflammation and preventing allergic reactions.

EMZUMAB 150 mg is administered as a subcutaneous injection under medical supervision at regular intervals depending on the patient’s condition and IgE levels.

Omalizumab is globally marketed under the reference brand Xolair.

Sky High Medex supplies genuine EMZUMAB 150 mg Injection with secure packaging and reliable worldwide delivery.

VECTIBIX 100 mg Injection contains Panitumumab, a fully human monoclonal antibody used in the treatment of metastatic colorectal cancer (mCRC). It specifically targets the epidermal growth factor receptor (EGFR), helping to slow or stop cancer cell growth.

Panitumumab binds to EGFR on cancer cells and blocks the signaling pathways responsible for tumor cell proliferation and survival. It is primarily indicated for RAS wild-type metastatic colorectal cancer.

VECTIBIX is the original reference brand of Panitumumab, manufactured and globally marketed by Amgen under the brand name Vectibix.

Sky High Medex supplies genuine VECTIBIX 100 mg Injection with secure cold-chain shipping and worldwide delivery.

BIOMAb EGFR Injection contains Nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). It works by binding specifically to EGFR on tumor cells, inhibiting cell proliferation, angiogenesis, and tumor progression.

BIOMAb EGFR (Nimotuzumab) is commonly used in the treatment of EGFR-expressing cancers, including head and neck cancer and certain brain tumors. It is administered under the supervision of a qualified oncologist.

BIOMAb EGFR is a branded formulation of Nimotuzumab.

Sky High Medex supplies genuine BIOMAb EGFR Injection with secure packaging and reliable international delivery.